Aldosterone Antagonists in Addition to Renin Angiotensin System Antagonists for Preventing the Progression of CKD: Editorial Summary of a Cochrane Review.
作者信息
Chung Edmund Y M, Strippoli Giovanni F M
机构信息
Department of Medicine, Royal North Shore Hospital, Sydney, Australia.
Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy; Cochrane Kidney and Transplant, Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia; School of Public Health, University of Sydney, Sydney, Australia.
出版信息
Am J Kidney Dis. 2021 May;77(5):810-812. doi: 10.1053/j.ajkd.2020.11.019. Epub 2021 Jan 5.
PMID:33418014
Abstract
摘要
相似文献
1
Aldosterone Antagonists in Addition to Renin Angiotensin System Antagonists for Preventing the Progression of CKD: Editorial Summary of a Cochrane Review.除肾素血管紧张素系统拮抗剂外，醛固酮拮抗剂用于预防慢性肾脏病进展：Cochrane系统评价的编辑总结
Am J Kidney Dis. 2021 May;77(5):810-812. doi: 10.1053/j.ajkd.2020.11.019. Epub 2021 Jan 5.
2
Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade.钠-葡萄糖共转运蛋白 2 抑制剂和非甾体类盐皮质激素受体拮抗剂：在肾素-血管紧张素系统阻断之外开创肾脏保护的新时代。
Nephrology (Carlton). 2021 Nov;26(11):858-871. doi: 10.1111/nep.13917. Epub 2021 Jul 6.
3
Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases.慢性肾脏病中肾素-血管紧张素-醛固酮系统的全面抑制：面面俱到。
Kidney Int. 2006 Dec;70(12):2051-3. doi: 10.1038/sj.ki.5002007.
4
[Renoprotective treatments : renin-angiotensin-aldosterone system blockade and beyond].[肾脏保护治疗：肾素-血管紧张素-醛固酮系统阻断及其他]
Rev Prat. 2024 Jun;74(6):s19-s22.
5
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.除肾素-血管紧张素系统拮抗剂外，醛固酮拮抗剂用于预防慢性肾脏病进展。
Cochrane Database Syst Rev. 2020 Oct 27;10(10):CD007004. doi: 10.1002/14651858.CD007004.pub4.
6
Renalism with Renin Angiotensin Aldosterone System Blockade: What Is the Consensus in Advanced Chronic Kidney Disease?肾素-血管紧张素-醛固酮系统阻断与肾脏疾病：晚期慢性肾脏病的共识是什么？
Can J Cardiol. 2024 Sep;40(9):1729-1731. doi: 10.1016/j.cjca.2024.04.027. Epub 2024 May 20.
7
The Factors Associated With Hyperkalemia-Induced Electrocardiogram Changes in the Outpatient Setting.
Am J Cardiol. 2024 Jan 15;211:141-142. doi: 10.1016/j.amjcard.2023.10.054. Epub 2023 Nov 7.
8
How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?面对心肾综合征时，我们应如何调整推荐的肾素-血管紧张素-醛固酮系统抑制治疗？
Circ Heart Fail. 2014 May;7(3):536. doi: 10.1161/CIRCHEARTFAILURE.113.000843.
9
Inhibition of the renin-angiotensin-aldosterone system: how to obtain this.肾素-血管紧张素-醛固酮系统的抑制：如何实现这一点。
Curr Pharm Des. 2012;18(7):950-1. doi: 10.2174/138161212799436494.
10
Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.肾素-血管紧张素-醛固酮系统抑制：血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂、盐皮质激素受体拮抗剂及直接肾素抑制剂治疗用途概述
Prim Care. 2014 Dec;41(4):765-78. doi: 10.1016/j.pop.2014.08.002. Epub 2014 Sep 29.
引用本文的文献
1
Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets.慢性肾脏病中的纤维化：病理生理学与治疗靶点
J Clin Med. 2024 Mar 25;13(7):1881. doi: 10.3390/jcm13071881.
2
Prevalence and Risk Factors Associated with Potentially Inappropriate Prescribing According to STOPP-2 Criteria among Discharged Older Patients-An Observational Retrospective Study.根据STOPP-2标准，出院老年患者中潜在不适当处方的患病率及相关危险因素——一项观察性回顾性研究
Pharmaceuticals (Basel). 2023 Jun 7;16(6):852. doi: 10.3390/ph16060852.
3
The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis.双重肾素-血管紧张素-醛固酮系统（RAAS）抑制与糖尿病肾病患者急性肾损伤和高钾血症风险之间的关联：一项系统评价和荟萃分析。
Nephrol Dial Transplant. 2023 Oct 31;38(11):2503-2516. doi: 10.1093/ndt/gfad101.
4
Huoxue Jiedu Huayu recipe alleviates contralateral renal fibrosis in unilateral ureteral obstruction rats by inhibiting the transformation of macrophages to myofibroblast.活血解毒化瘀方通过抑制巨噬细胞向肌成纤维细胞的转化缓解单侧输尿管梗阻大鼠的对侧肾脏纤维化。
J Tradit Chin Med. 2023 Feb;43(1):105-112. doi: 10.19852/j.cnki.jtcm.2023.01.009.
5
Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys.原发性醛固酮增多症与醛固酮受体拮抗剂在心脏和肾脏中的作用。
Annu Rev Med. 2023 Jan 27;74:217-230. doi: 10.1146/annurev-med-042921-100438. Epub 2022 Nov 14.
Zotero 插件